New CT imaging oral contrast agent improves visualization of bowel anatomy, clinical trial data show
FacebookEmailLinkedinA new oral contrast agent for CT imaging has shown improved visualization of bowel anatomy in clinical trials. Compared to traditional agents, it provides clearer images, which can help radiologists better detect and evaluate gastrointestinal conditions. The results suggest it could enhance diagnostic accuracy and patient care in abdominal imaging.